1st February 2018
The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of Baseball Australia to impose a four-year ban on Canberra Cavalry player Jason Sloan for the presence and use of a prohibited substance.
ASADA collected an in-competition sample from Mr Sloan on 15 December 2016 at an Australian Baseball League game in Canberra.
His sample was analysed at the Australian Sports Drug Testing Laboratory, part of the National Measurement Institute, which detected the presence of 5b-androst-1-en-17b-ol-3-one, a metabolite of Boldenone.
Boldenone is banned at all times under the S1.1 class of Anabolic Androgenic Steroids on the World Anti-Doping Agency’s Prohibited List. It was developed for use in veterinary medicine for the treatment of horses and is not approved for human use. Some of the potential side effects include permanent liver damage, heart problems, aggressiveness and infertility.
As a result of the substances used, Mr Sloan received a mandatory provisional suspension in May 2017. Mr Sloan waived his right to a hearing and did not contest the sanction.
The decision means Mr Sloan is ineligible to participate, as an athlete or support person, in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 2 May, 2021.